Stress-induced changes in pathophysiology and interferon gene expression during primary HSV-1 infection

Brain, Behavior, and Immunity

Volumn 17, Issue 5, 2003, Pages 329-338

  Ortiz, Griselle C ^a   Sheridan, John F ^a   Marucha, Phillip T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Gene expression; HSV 1; IFN ; IFN ; IFN ; RT PCR; RU486; Stress

Indexed keywords

GLUCOCORTICOID RECEPTOR ANTAGONIST; INTERFERON; MIFEPRISTONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; MALE; MODEL; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; STRESS; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0043236288     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(03)00027-8     Document Type: Article

References (46)

1. Ahmad A., Sharif-Askari E., Fawaz L., Menezes J. Innate immune response of the human host to exposure with herpes simplex virus type 1: In vitro control of the virus infection by enhanced natural killer activity via interlukin-15 induction. J. Virol. 74:2000;7196-7203.
2. Awan A.R., Harmenberg J., Flink O., Field H.J. Combinations of antiviral and anti-inflammatory preparations for the topical treatment of herpes simplex virus assessed using a murine zosteriform infection model. Antivir. Chem. Chemother. 9:1998;19-24.
3. Biron C.A. Role of early cytokines, including α and β interferons (IFN-α/beta), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10:1998;383-390.
4. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu. Rev. Immunol. 17:1999;189-220.
5. Blondeau J.M., Aoki F.Y., Glavin G.B. Stress-induced reactivation of latent herpes simplex virus infection in the rat lumbar dorsal root ganglia. J. Psychosom. Res. 37:1993;843-849.
6. Bonneau R.H., Sheridan J.F., Feng N., Glaser R. Stress induced suppression of herpes simplex virus (HSV)-specific cytotoxic T lymphocyte and natural killer cell activity and enhancement of acute pathogenesis following local HSV infection. Brain Behav. Immun. 5:1991;170-192.
7. Brenner G.J., Moynihan J.A. Stressor-induced alterations in immune response and viral clearance following infection with herpes simplex virus type-1 in BALB/c and C57BI/6 mice. Brain Behav. Immun. 11:1997;9-23.
8. Dijkmans R., Volckaert G., Van Damme J., De Ley M., Billiau A., De Somer P. Molecular cloning of murine interferon γ (MuIFN-γ) cDNA and its expression in heterologous mammalian cells. J. Interferon Res. 5:1985;511-520.
9. Dobbs C.M., Vasquez M., Glaser R., Sheridan J.F. Mechanisms of stress-induced modulation of viral pathogenesis and immunity. J. Neuroimmunol. 48:1993;151-160.
10. Dorries R. The role of T-cell mediated mechanisms in virus infections of the nervous system. Curr. Top. Microbiol. Immunol. 253:2001;219-245.
11. Feng N., Pagniano R., Tovar C.A., Bonneau R.H., Glaser R., Sheridan J.F. The effect of restraint stress on the kinetics, magnitude, and isotype of the humural immune response to influenza virus infection. Brain Behav. Immun. 5:1991;370-382.
12. Hardwicke M.A., Schaffer P.A. Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL-and oriS-dependent DNA replication in PC12 cells. J. Virol. 71:1997;3580-3587.
13. Hermann G., Tovar C.A., Beck F.M., Sheridan J.F. Kinetics of glucocorticoid response to restraint stress and/or experimental influenza viral infection in two inbred strains of mice. J. Neuroimmunol. 49:1994;25-33.
14. Hill T.J. Herpes simplex virus latency. Roizman B. The herpesviruses. 1985;175 Plenum Press, New York.
15. Hughes T., Chin R., Tyring S., Rady P. Distinction of mouse interferon-α subtypes by polymerase chain reaction utilizing consensus primers and type-specific oligonucleotide probes. J. Interferon Res. 14:1994;117-120.
16. Iwakabe K., Shimada M., Ohta A., Yahata T., Ohmi Y., Habu S., Nishimura T. The restraint stress drives a shift in Th1/Th2 balance toward Th2-dominant. Immunol. Lett. 62:1998;39-43.
17. Kadowaki N., Antonenko S., Lau J., Liu Y. Natural interferon α/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 192:2000;219-226.
18. Kristensson K., Lycke E., Roytta M., Svennerholm B., Vahlne A. Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. Effects of substances interacting with microtubular function and axonal flow [nocodazole, taxol and erythro-9-3-(2-hydroxynonyl)adenine]. J. Gen. Virol. 67:1986;2023-2028.
19. Kusnecov A.V., Grota L.J., Schmidt S., Bonneau R.H., Sheridan J.F., Glaser R., Moynihan J.A. Decreased herpes simplex viral immunity and enhanced pathogenesis following stressor administration in mice. J. Neuroimmunol. 38:1992;129-138.
20. Mercado A.M., Padgett D.A., Sheridan J.F., Marucha P.T. Altered kinetics of IL-1α, IL-1β, and KGF gene expression in early wounds of restrained mice. Brain Behav. Immun. 16:2002;150-156.
21. Miranda-Saksena M., Armati P., Boadle R.S., Holland D.J., Cunningham A.L. Anterograde transport of herpes simplex virus type 1 in cultured, dissociated human and rat dorsal root ganglion cells. J. Virol. 74:2000;1827-1839.
22. Mo X.Y., Sarawar S.R., Doherty P.C. Induction of cytokines in mice with parainfluenza pneumonia. J. Virol. 69:1995;1288-1291.
23. Munck A., Guyre P.M. Glucocorticoids and immune function. Ader R., Felten D.L., Cohen N. Psychoneuroimmunology. 1991;Academic Press, San Diego.
24. Padgett D.A., Marucha P.M., Sheridan J.F. Restraint stress slows cutaneous wound healing in mice. Brain Behav. Immun. 12:1998;64-73.
25. Padgett D.A., Sheridan J.F., Dourne J., Berntson G.G., Candelora J., Glaser R. Social stress and the reactivation of latent herpes simplex virus type 1. Proc. Natl. Acad. Sci. USA. 95:1998;7231-7235.
26. Pereira F.A. Herpes simplex: Evolving concepts. J. Am. Acad. Dermatol. 35:1996;503-520.
27. Rafi-Janajerh A.Q., Nargarkatti P.S., Nargarkatti M. Role of CD44 in CTL and NK cell activity. Front. Biosci. 3:1998;D665-D671.
28. Roizman B., Sears A.E. Herpes simplex virus and their replication. Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Hirsh M.S., Melnick J.L. Fields' virology. 1996;2231-2295 Lippincott-Raven, Philadelphia.
29. Rytel M.W., Niebojewski R.A., Aguilar-Torres F.G., Russell T.J. Recurrent herpes simplex labialis: Viral replication and clinical course. Am. J. Med. Sci. 276:1978;319-323.
30. Sabath D., Broome H., Prystowsky M. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene. 91:1990;185-191.
31. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:2001;778-809.
32. Sawtell N. Comprehensive quantification of herpes simplex virus latency. J. Virol. 71:1997;5423-5431.
33. Sawtell N.M. The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J. Virol. 72:1998;6888-6892.
34. Schmid S., Rouse B.T. The role of T cell immunity in control of herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:1992;57-74.
35. Sheridan J., Kern E., Martin A., Booth A. Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections. Antivir. Res. 36:1997;157-166.
36. Sheridan J.F., Dobbs C., Jung J., Chu X., Konstantinos A., Padgett D., Glaser R. Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann. N.Y. Acad. Sci. 840:1998;803-808.
37. Sheridan J.F., Feng N., Bonneau R.H., Alien C.M., Hunneycutt B.S., Glaser R. Restraint stress differentially affects anti-viral cellular and humoral immune responses in mice. J. Neuroimmunol. 31:1991;245-255.
38. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264.
39. Tenser R.B., Hsiung G.D. Pathogenesis of latent herpes simplex virus infection of the trigeminal ganglia in guinea pigs: Effects of age, passive immunization, and hydrocortisone. Infect. Immun. 16:1977;69-74.
40. Tompkins W.A. Immunomodulation and therapeutic effects of the oral use of interferon α: Mechanism of action. J. Interferon Cytokine Res. 19:1999;817-828.
41. Topp K.S., Meade L.B., LaVail J.H. Microtubule polarity in the peripheral processes of trigeminal ganglion cells: Relevance for the retrograde transport of herpes simplex virus. J. Neurosci. 14:1994;318-325.
42. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376.
43. Weizman R., Bessler H. Cytokines: Stress and immunity - An overview. Plotnikoff N.P., Faith R.E., Murgo A.J., Good R.A. Cytokines - Stress and Immunity. 1999;1-16 CRC Press LLC, Boca Raton.
44. Welsh R.M. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J. Exp. Med. 148:1978;163-181.
45. Welsh R.M., Zinkernagel R.M. Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in the mice. Nature. 268:1977;646-648.
46. Yu Z., Manickan E., Rouse B.T. Role of interferon-γ in immunity to herpes simplex virus. J. Leukoc. Biol. 60:1996;528-532.